Effect of Yeast Beta Glucan (Saccharomyces cerevisiae) compared to a placebo on cold and flu symptoms in an Adult Population – A double blind, randomised controlled trial.

RDC Global Pty Ltd.0 个研究点目标入组 240 人开始时间: 2020年11月27日最近更新: 2022年3月7日

适应症

试验速览

暂无简介。

•Male and females aged 18-65 years old
•Able to provide informed consent
•Agree not to take any beta-glucan supplement or any other supplements (e.g. Echinacea, Vitamin C, zinc) or medications (e.g. Tamiflu, Relenza) aimed at preventing URTIs for the duration of the trial (3 months).

•Unstable or serious illness (e.g. kidney, liver, GIT, heart conditions, diabetes, thyroid gland function, Malignancy, lung conditions or chronic asthma)*
•Anyone regularly (> 3 times per week) consuming unprocessed food high in beta-glucan or with added beta-glucan (e.g. oats, barley and shiitake mushrooms)
•Acute sickness experienced in the past 2 months
•Serious mood disorders or neurological disorders such as MS
•Active smokers and/or nicotine or drug abuse
•Chronic alcohol use (>14 alcoholic drinks week)
•Allergic to any of the ingredients in active or placebo formula
•Pregnant or lactating woman
•People medically prescribed medications that would affect the immune and/or the inflammatory response.
•Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
•Participants who have participated in any other related clinical study during the past 1 month
•People with cognitive damage
•People who have or have had treatment for cancer, HIV or chronic use of any dose of steroids (cream, tablet or inhalant) in the past year
•*An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.

发起方